|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Marumoto T and Saya H: Molecular biology
of glioma. Adv Exp Med Biol. 746:2–11. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Calin GA, Sevignani C, Dumitru CD, Hyslop
T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M
and Croce CM: Human microRNA genes are frequently located at
fragile sites and genomic regions involved in cancers. Proc Natl
Acad Sci USA. 101:pp. 2999–3004. 2004, View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Croce CM and Calin GA: miRNAs, cancer, and
stem cell division. Cell. 122:6–7. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
An L, Liu Y, Wu A and Guan Y: microRNA-124
inhibits migration and invasion by down-regulating ROCK1 in glioma.
PLoS One. 8:e694782013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jia Z, Wang K, Wang G, Zhang A and Pu P:
MiR-30a-5p antisense oligonucleotide suppresses glioma cell growth
by targeting SEPT7. PLoS One. 8:e550082013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lei H, Zou D, Li Z, Luo M, Dong L, Wang B,
Yin H, Ma Y, Liu C, Wang F, et al: MicroRNA-219-2-3p functions as a
tumor suppressor in gastric cancer and is regulated by DNA
methylation. PLoS One. 8:e603692013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huang N, Lin J, Ruan J, Su N, Qing R, Liu
F, He B, Lv C, Zheng D and Luo R: MiR-219-5p inhibits
hepatocellular carcinoma cell proliferation by targeting
glypican-3. FEBS Lett. 586:884–891. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jiang Y, Yin L, Jing H and Zhang H:
MicroRNA-219-5p exerts tumor suppressor function by targeting ROBO1
in glioblastoma. Tumour Biol. 36:8943–8951. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rao SA, Arimappamagan A, Pandey P, Santosh
V, Hegde AS, Chandramouli BA and Somasundaram K: miR-219-5p
inhibits receptor tyrosine kinase pathway by targeting EGFR in
glioblastoma. PLoS One. 8:e631642013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Komori T: The 2016 WHO classification of
tumours of the central nervous system: The major points of
revision. Neurol Med Chir (Tokyo). 57:301–311. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Terret C, Albrand G, Moncenix G and Droz
JP: Karnofsky performance scale (KPS) or physical performance test
(PPT)? That is the question. Crit Rev Oncol Hematol. 77:142–147.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shi JA, Lu DL, Huang X and Tan W: miR-219
inhibits the proliferation, migration and invasion of
medulloblastoma cells by targeting CD164. Int J Mol Med.
34:237–243. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rao SA, Santosh V and Somasundaram K:
Genome-wide expression profiling identifies deregulated miRNAs in
malignant astrocytoma. Mod Pathol. 23:1404–1417. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen X, Vega VB and Ng HH: Transcriptional
regulatory networks in embryonic stem cells. Cold Spring Harb Symp
Quant Biol. 73:203–209. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Han SX, Wang JL, Guo XJ, He CC, Ying X, Ma
JL, Zhang YY, Zhao Q and Zhu Q: Serum SALL4 is a novel prognosis
biomarker with tumor recurrence and poor survival of patients in
hepatocellular carcinoma. J Immunol Res. 2014:2623852014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Deng G, Zhu L, Huang F, Nie W, Huang W, Xu
H, Zheng S, Yi Z and Wan T: SALL4 is a novel therapeutic target in
intrahepatic cholangiocarcinoma. Oncotarget. 6:27416–27426. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Forghanifard MM, Khales Ardalan S,
Javdani-Mallak A, Rad A, Farshchian M and Abbaszadegan MR: Stemness
state regulators SALL4 and SOX2 are involved in progression and
invasiveness of esophageal squamous cell carcinoma. Med Oncol.
31:9222014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang L, Xu Z, Xu X, Zhang B, Wu H, Wang
M, Zhang X, Yang T, Cai J, Yan Y, et al: SALL4, a novel marker for
human gastric carcinogenesis and metastasis. Oncogene.
33:5491–5500. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kobayashi D, Kuribayashi K, Tanaka M and
Watanabe N: Overexpression of SALL4 in lung cancer and its
importance in cell proliferation. Oncol Rep. 26:965–970.
2011.PubMed/NCBI
|
|
25
|
Oikawa T, Kamiya A, Zeniya M, Chikada H,
Hyuck AD, Yamazaki Y, Wauthier E, Tajiri H, Miller LD, Wang XW, et
al: Sal-like protein 4 (SALL4), a stem cell biomarker in liver
cancers. Hepatology. 57:1469–1483. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang L, Yan Y, Jiang Y, Cui Y, Zou Y,
Qian J, Luo C, Lu Y and Wu X: The expression of SALL4 in patients
with gliomas: High level of SALL4 expression is correlated with
poor outcome. J Neurooncol. 121:261–268. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
He J, Zhang W, Zhou Q, Zhao T, Song Y,
Chai L and Li Y: Low-expression of microRNA-107 inhibits cell
apoptosis in glioma by upregulation of SALL4. Int J Biochem Cell
Biol. 45:1962–1973. 2013. View Article : Google Scholar : PubMed/NCBI
|
